These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7526634)

  • 1. Autoantibody activity and V gene usage by B-cell malignancies.
    Dighiero G
    Adv Exp Med Biol; 1994; 347():125-33. PubMed ID: 7526634
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibody activity and V gene usage by B-cell malignancies.
    Dighiero G
    Leuk Lymphoma; 1992 Nov; 8(4-5):345-51. PubMed ID: 1283965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors.
    Stevenson FK; Spellerberg MB; Chapman CJ; Hamblin TJ
    Leuk Lymphoma; 1995 Feb; 16(5-6):379-84. PubMed ID: 7787747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of human antibody variable genes in systemic autoimmunity.
    Zouali M
    Immunol Rev; 1992 Aug; 128():73-99. PubMed ID: 1427924
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin gene usage in diabetes-associated human monoclonal antibodies recognizing glutamate decarboxylase.
    Richter W; Jury KM; Loeffler D; Eiermann TH; Boehm BO
    Ann N Y Acad Sci; 1995 Sep; 764():457-60. PubMed ID: 7486565
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of VH11+ B cells: a model for selection of B cells producing natural autoantibodies.
    Hardy RR
    Curr Dir Autoimmun; 2003; 6():196-211. PubMed ID: 12408053
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin V gene expression in CD5 B-cell malignancies.
    Kipps TJ; Rassenti LZ; Duffy S; Johnson T; Kobayashi R; Carson DA
    Ann N Y Acad Sci; 1992 May; 651():373-83. PubMed ID: 1376056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift.
    Mo JA; Holmdahl R
    J Immunol; 1996 Sep; 157(6):2440-8. PubMed ID: 8805643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
    Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
    Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant CD5 B cells--biased immunoglobulin variable gene usage and autoantibody production.
    Mayer R; Stone K; Han A; Bona C
    Int Rev Immunol; 1991; 7(3):189-203. PubMed ID: 1721931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune syndrome after neonatal induction of tolerance to alloantigens: analysis of the specificity and of the cellular and genetic origin of autoantibodies.
    Schurmans S; Merino J; Qin HY; Kramar G; Duchosal M; Skalli O; Benzonana G; Gabbiani G; Lambert PH
    Autoimmunity; 1991; 9(4):283-91. PubMed ID: 1720028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell malignancies frequently reflect expansion of the autoreactive B cell repertoire, although the mechanism accounting for this remains controversial.
    Dighiero G
    Blood Cells; 1993; 19(3):626-30; discussion 631-2. PubMed ID: 8018943
    [No Abstract]   [Full Text] [Related]  

  • 13. Fine specificity, idiotypy, and nature of cloned heavy-chain variable region genes of murine monoclonal rheumatoid factor antibodies.
    Manheimer-Lory AJ; Monestier M; Bellon B; Alt FW; Bona CA
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8293-7. PubMed ID: 3095832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities.
    Monestier M; Manheimer-Lory A; Bellon B; Painter C; Dang H; Talal N; Zanetti M; Schwartz R; Pisetsky D; Kuppers R
    J Clin Invest; 1986 Sep; 78(3):753-9. PubMed ID: 2427543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VH gene expression in CD5 positive and CD5 negative B cell chronic lymphoid malignancies.
    Maloum K; Pritsch O; Magnac C; Davi F; Binet JL; Merle-Beral H; Dighiero G
    Leuk Lymphoma; 1997 Feb; 24(5-6):437-48. PubMed ID: 9086435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and regulation of clonally ignorant B cells.
    Thomas JW; Hulbert C
    Ann N Y Acad Sci; 1995 Sep; 764():461-2. PubMed ID: 7486566
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization, specificity, and IgV gene usage of anti-lymphocyte monoclonal antibodies from perinatal mice.
    Lehuen A; Bartels J; Kearney JF
    Int Immunol; 1992 Oct; 4(10):1073-84. PubMed ID: 1489727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice.
    Souroujon M; White-Scharf ME; Andreschwartz J; Gefter ML; Schwartz RS
    J Immunol; 1988 Jun; 140(12):4173-9. PubMed ID: 2453571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice.
    Painter CJ; Monestier M; Chew A; Bona-Dimitriu A; Kasturi K; Bailey C; Scott VE; Sidman CL; Bona CA
    J Exp Med; 1988 Mar; 167(3):1137-53. PubMed ID: 3351435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.